Brisson M - Search Results

1

Accounting for methodological, structural, and parameter uncertainty in decision-analytic models: a practical guide.

Bilcke J, Beutels P, Brisson M, Jit M. Bilcke J, et al. Among authors: brisson m. Med Decis Making. 2011 Jul-Aug;31(4):675-92. doi: 10.1177/0272989X11409240. Epub 2011 Jun 8. Med Decis Making. 2011. PMID: 21653805

2

Impact of model, methodological, and parameter uncertainty in the economic analysis of vaccination programs.

Brisson M, Edmunds WJ. Brisson M, et al. Med Decis Making. 2006 Sep-Oct;26(5):434-46. doi: 10.1177/0272989X06290485. Med Decis Making. 2006. PMID: 16997923

3

Proceedings of the Modeling Evidence in HPV Pre-Conference Workshop in Malmö, Sweden, May 9-10, 2009.

Craig BM, Brisson M, Chesson H, Giuliano AR, Jit M. Craig BM, et al. Among authors: brisson m. Clin Ther. 2010 Aug;32(8):1546-64. doi: 10.1016/j.clinthera.2010.06.017. Clin Ther. 2010. PMID: 20728767 Free PMC article.

4

Modelling the epidemiology of infectious diseases for decision analysis: a primer.

Jit M, Brisson M. Jit M, et al. Among authors: brisson m. Pharmacoeconomics. 2011 May;29(5):371-86. doi: 10.2165/11539960-000000000-00000. Pharmacoeconomics. 2011. PMID: 21504239 Free PMC article. Review.

5

Cross-protective efficacy of two human papillomavirus vaccines: a systematic review and meta-analysis.

Malagón T, Drolet M, Boily MC, Franco EL, Jit M, Brisson J, Brisson M. Malagón T, et al. Among authors: brisson m, brisson j. Lancet Infect Dis. 2012 Oct;12(10):781-9. doi: 10.1016/S1473-3099(12)70187-1. Epub 2012 Aug 22. Lancet Infect Dis. 2012. PMID: 22920953 Review.

6

Dynamic transmission modeling: a report of the ISPOR-SMDM Modeling Good Research Practices Task Force Working Group-5.

Pitman R, Fisman D, Zaric GS, Postma M, Kretzschmar M, Edmunds J, Brisson M; ISPOR-SMDM Modeling Good Research Practices Task Force. Pitman R, et al. Among authors: brisson m. Med Decis Making. 2012 Sep-Oct;32(5):712-21. doi: 10.1177/0272989X12454578. Med Decis Making. 2012. PMID: 22990086

7

Economic analyses to support decisions about HPV vaccination in low- and middle-income countries: a consensus report and guide for analysts.

Jit M, Levin C, Brisson M, Levin A, Resch S, Berkhof J, Kim J, Hutubessy R. Jit M, et al. Among authors: brisson m. BMC Med. 2013 Jan 30;11:23. doi: 10.1186/1741-7015-11-23. BMC Med. 2013. PMID: 23363734 Free PMC article.

8

Two-dose strategies for human papillomavirus vaccination: how well do they need to protect?

Jit M, Choi YH, Laprise JF, Boily MC, Drolet M, Brisson M. Jit M, et al. Among authors: brisson m. Vaccine. 2014 May 30;32(26):3237-42. doi: 10.1016/j.vaccine.2014.03.098. Epub 2014 Apr 13. Vaccine. 2014. PMID: 24726246

9

Cost-effectiveness of female human papillomavirus vaccination in 179 countries: a PRIME modelling study.

Jit M, Brisson M, Portnoy A, Hutubessy R. Jit M, et al. Among authors: brisson m. Lancet Glob Health. 2014 Jul;2(7):e406-14. doi: 10.1016/S2214-109X(14)70237-2. Epub 2014 Jun 9. Lancet Glob Health. 2014. PMID: 25103394 Free article.

10

Comparing the cost-effectiveness of two- and three-dose schedules of human papillomavirus vaccination: a transmission-dynamic modelling study.

Laprise JF, Drolet M, Boily MC, Jit M, Sauvageau C, Franco EL, Lemieux-Mellouki P, Malagón T, Brisson M. Laprise JF, et al. Among authors: brisson m. Vaccine. 2014 Oct 7;32(44):5845-53. doi: 10.1016/j.vaccine.2014.07.099. Epub 2014 Aug 12. Vaccine. 2014. PMID: 25131743 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

223 results

Search Page

Filters